Document is current
Any future updates will be listed below
-
Authors
Dart, Sarah J.
Cook, Alistair M.
Millward, Michael J.
McDonnell, Alison M.
Chin, Wee L.
Hakeem, Muhammad U.
Meniawy, Tarek M.
Bowyer, Samantha E.
-
Funding
Funding for this research was provided by:
Cancer Council Western Australia (Suzanne Cavanagh Early Career Investigator Grant (number 452))
- License Information
-
More Information
Article History
Received: 10 December 2020
Accepted: 17 June 2021
First Online: 28 July 2021
Competing interests
: M.J.M. and T.M.M. declare serving on the advisory boards for AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme and Novartis. M.J.M. also declares serving on the advisory boards for Pfizer and Roche. M.J.M. and T.M.M. declare receiving travel support from AstraZeneca, Bristol-Meyers Squibb and Roche. S.J.D., A.M.C., A.M.M., W.L.C, M.U.H. and S.E.B. declare they have no competing interests related to the work described.
